The Suit Magazine

Nicholas Landekic, CEO of PolyMedix Inc., has taken the road less traveled in the pharmaceutical business. After more than ten years working for big pharma and in research, he had earned a secure place in their workforce. But with true entrepreneurial spirit, he eschewed that comfort and went out on his own. Today, he is working on a class of new drugs that imitate antimicrobial peptides to kill bacteria, with the bacteria unlikely to develop resistance. PolyMedix calls these new antibiotic compounds “defensin-mimetics.”

Ron Najafi, Ph.D., has been working on a revolutionary type of drug which offers hope in the fight against antibiotic-resistant infections. As Najafi told us, “Antibiotics have been the wonder drug of the 20th Century, but, unfortunately, over the last 40-50 years, significant bacterial resistance has developed through the misuse and overuse of those antibiotics.”

Things are looking good for Justin Dowel, the heir apparent to the small Australian-based empire of Nature’s Organics. The eco-friendly corporation has a strong track record of using both environmentally responsible products and packaging.

Dr. John Tang told us, “I think I have uncovered the closest thing to the fountain of youth. Who wouldn't want to feel as young as long as possible and look 10-20 years younger than their age?” Many have made that claim, but Dr. Tang has the credentials and clinical experience to back it up.

After Michael Clark, CEO of Kern Regional Center, discovered that his daughter had Downs Syndrome, he quickly decided to switch his career. “When I had the opportunity to take the job as executive director, it was exactly what I wanted to do,” Clark said during an interview with The Suit Magazine.

From a young age, Dr. Wayne Scott Andersen was struck by the rampant epidemic of obesity that plagues the United States and other western societies. In the United States 32.2% of the population is classified as obese while another 30% are classified as overweight. After a long career in traditional medicine he had a revelation.

Advaxis, Inc. is a biotechnology company on the cutting edge of medical innovation, using a bioengineered bacterium, Listeria monocytogenes, to activate the human immune system. It is a powerful weapon, with the potential to treat multiple cancers, viral infectious diseases and allergic syndromes.

Rhode Island-based CVS Pharmacy launching an exclusive club for its makeup and beauty product customers.